MutL homologs belong to a family of proteins that share a conserved ATP binding site. We demonstrate that amino-terminal domains of the yeast MutL homologs Mlh1 and Pms1 required for DNA mismatch repair both possess independent, intrinsic ATPase activities. Amino acid substitutions in the conserved ATP binding sites concomitantly reduce ATP binding, ATP hydrolysis, and DNA mismatch repair in vivo. The ATPase activities are weak, consistent with the hypothesis that ATP binding is primarily responsible for modulating interactions with other MMR components. Three approaches, ATP hydrolysis assays, limited proteolysis protection, and equilibrium dialysis, provide evidence that the amino-terminal domain of Mlh1 binds ATP with >10-fold higher affinity than does the amino-terminal domain of Pms1. This is consistent with a model wherein ATP may first bind to Mlh1, resulting in events that permit ATP binding to Pms1 and later steps in DNA mismatch repair.
Correction of DNA replication errors by the general DNA mismatch repair (MMR) 1 system is one of several cellular processes contributing to mutation avoidance and genomic stability. MMR defects result in increased spontaneous mutation rates and susceptibility to cancer in humans and mice (reviewed recently in Refs. 1 and 2). Several proteins are essential for DNA mismatch repair in prokaryotes and eukaryotes, including bacterial MutL and its eukaryotic homologs. In Escherichia coli, homodimeric MutL protein coordinates the MMR pathway by interacting with and modulating the activity of other proteins, including MutS, MutH, and UvrD (1, 2) . In eukaryotes, matchmaking functions are thought to be performed by heterodimeric complexes of MutL homologs.
MutL and its homologs belong to the GHKL family of proteins, which includes type II topoisomerases, the hsp90 chaperone proteins, and histidine kinases (3) (4) (5) . GHKL family members all share conserved amino acid motifs implicated in ATP binding and hydrolysis. Consistent with this fact, E. coli MutL binds ATP, resulting in a large conformational change in the protein (6) . MutL also catalyzes a weak ATPase reaction (7) that is thought to be required for DNA mismatch repair (8) .
Based on their homology to MutL and the other GHKL family members, eukaryotic MutL homologs are also expected to bind and hydrolyze ATP. In yeast, mutation rate measurements indicate that amino acids in the conserved ATP binding motifs of Mlh1 and Pms1 are essential for mismatch repair, and partial proteolysis experiments indicate that Mlh1 undergoes an ATP-induced conformational change (9) . Here, we provide direct evidence that yeast Mlh1 and Pms1 both bind and hydrolyze ATP independently of each other and that they both change conformation upon ATP binding. Moreover, we provide three lines of evidence that Mlh1 binds ATP with substantially higher affinity than does Pms1. The results suggest that proper coordination of the MMR pathway may involve sequential binding of ATP, first to one then the other ATP binding site in the Mlh1-Pms1 heterodimer.
EXPERIMENTAL PROCEDURES
Plasmids-Regions of yeast MLH1 encoding amino acids 1-343 and PMS1 encoding amino acids 32-396 were amplified by PCR using pMH1 (10) and pMH8 (11) as templates, respectively. NcoI and NotI restriction enzyme sites introduced by the primers were used to clone the PCR products into pET30a (Novagen). The constructs allowed isopropyl-␤-D-thiogalactopyranoside-induced production of the two proteins, designated Mlh1(343) and Pms1(396), as fusions with a 6-His tag for nickel affinity purification. Missense mutations in Mlh1(343) and Pms1(396) were made directly in these constructs using the QuikChange site-directed mutagenesis kit (Stratagene). MLH1 and PMS1 alleles were sequenced using an ABI PRISM 377 DNA sequencer (PerkinElmer Life Sciences) to confirm the correct sequence. The URA3-based yeast integrative plasmid YIpMLH1 has been described previously (12) . The 2 -based plasmid pMMR82 containing the yeast PMS1 gene with 5Ј upstream and 3Ј downstream regions cloned in YEplac195 (13) was kindly provided by L. Prakash (University of Texas). To create plasmid YIpPMS1, a 4.4-kb SalI fragment with the PMS1 gene from pMMR82 was cloned into the SalI site of yeast integrative URA3 plasmid pRS306 (14) . Missense mutations in the MLH1 and PMS1 genes were created in YIpMLH1 and YIpPMS1 by site-directed PCR mutagenesis and confirmed by partial sequencing of MLH1 and PMS1 as described previously (12) . For construction of mutant yeast strains, at least three independently obtained mutant derivatives of YIpMLH1 or YIpPMS1 were used.
Yeast Strains-Saccharomyces cerevisiae haploid strains E134 (MAT␣ ade5 lys2::InsE A14 trp1-289 his7-2 leu2-3,112 ura3-52) and E68 (MAT␣ ade2-1 arg4-8 leu2-3,112 thr1-4 trp1-1 ura3-52 lys2⌬ cup1-1) and mlh1⌬ and pms1⌬ derivatives of E134 have been described previously (11, 12) . To create haploid strains with missense mutations in the MLH1 gene, the chromosomal MLH1 gene in strain E134 was replaced with the mutant alleles using mutant derivatives of plasmid YIpMLH1 as described previously (12) . Haploid strains with mutations in the PMS1 gene were constructed in a similar way using mutant derivatives of plasmid YIpPMS1 cut with HpaI. Diploid strains heterozygous for mlh1 or pms1 mutations and a control wild-type diploid were constructed by crossing E68 to E134 or its mlh1 or pms1 mutants.
Mutation Rate Measurements-Rates of lys2::InsE A14 and his7-2 reversion and forward mutation to canavanine resistance were measured by fluctuation analysis as described previously (12) .
Protein Purification-Proteins were overproduced from pET30a in E. coli BL21(DE3)pLysS. A single transformant was grown up to 5 liters in 2ϫYT medium under antibiotic selection at 30°C. At an optical density (600 nm) of 0.75, 0.5 mM isopropyl-␤-D-thiogalactopyranoside (Invitrogen) was added to the 5-liter cultures, and growth was continued for 4 h. Cells were harvested by centrifugation and frozen at Ϫ20°C. All subsequent steps were performed at 4°C. The protocols for purification of Mlh1(343), Pms1(396), and all mutants were identical. Thawed cells were resuspended in 100 ml of buffer A (25 mM NaPO 4 , pH 7.6 at 23°C, 10% glycerol, 0.1 mM EDTA, 500 mM NaCl, and 5 mM 2-mercaptoethanol) containing 10 mM imidazole, Complete EDTA-free protease inhibitors (Roche Molecular Biochemicals), and 0.5 mM phenylmethylsulfonyl fluoride. The cell suspension was sonicated using a model W140 Cell Disrupter (Branson Sonic Power Co.) to achieve a water-like viscosity and cleared by centrifugation at 30,000 ϫ g for 30 min.
The cleared lysate was loaded onto a 5-ml nickel-nitrilotriacetic acid superflow (Qiagen) column (1.5 cm inner diameter) equilibrated with buffer A ϩ 10 mM imidazole at 1.0 ml/min. The column was washed with 50 ml of buffer A ϩ 20 mM imidazole and developed with a linear gradient of imidazole (20 -250 mM) in buffer A while collecting 1.0-ml fractions. Fractions containing the desired protein were pooled and dialyzed overnight against 1 liter of buffer B (25 mM Tris-HCl, pH 8.0 at 23°C, 10% glycerol, 10 mM dithiothreitol, and 0.1 mM EDTA) containing 100 mM NaCl. The dialysate was loaded onto a 5-ml HiTrap heparinSepharose column (Amersham Biosciences, Inc.) equilibrated with buffer B ϩ 100 mM NaCl. This column was washed with 25 ml of the same buffer and developed with a linear gradient of NaCl (100 -750 mM) in buffer B while collecting 1.0-ml fractions. Fractions containing the desired protein (elution peak at ϳ500 mM NaCl) were pooled and dialyzed overnight against 1 liter of buffer C (25 mM Tris-HCl, pH 8.0 at 23°C, 10% glycerol, 50 mM NaCl, 4 mM MgCl 2 , and 10 mM dithiothreitol).
To remove the 5-kDa affinity tag, the purified fusion proteins were treated with recombinant enterokinase (Novagen) as directed by the supplier, leaving Ala-Met-Ala attached to the amino terminus. The cleaved proteins were loaded by gravity flow onto a 1-ml singlestranded DNA cellulose (Amersham Biosciences, Inc.) column equilibrated with buffer C, washed with 3 ml of buffer C, and eluted with buffer C containing 500 mM NaCl. Proteins were dialyzed against either buffer C or buffer D (25 mM NaPO 4 , pH 7.6 at 23°C, 50 mM NaOAc, 10 mM dithiothreitol, and 4 mM MgCl 2 ), flash-frozen in liquid nitrogen, and stored in small aliquots at Ϫ80°C. Protein concentrations were determined by the method of Bradford (15) Partial Proteolysis-Reactions (20 l) were performed in buffer C and contained ϳ2.5 g of protein and the indicated concentration of a 1:1 ATP/MgCl 2 mixture. After 5 min to allow ATP binding, reactions were initiated with 125 ng of trypsin and incubated at room temperature for 45 min (Mlh1(343) and mutants) or 15 min (Pms1(396) and mutants). Reactions were stopped by addition of SDS loading dye, subjected to SDS-PAGE, and products visualized by Coomassie Blue staining. Digital image analysis was used to calculate the percentage of protein protected at each ATP concentration using the formula (P int Ϫ P 0 )/(P tot Ϫ P 0 ), where P int is the band intensity of the intact protein at a given ATP concentration, P tot is the band intensity of the intact protein in a mock reaction lacking trypsin, and P 0 is the band intensity of intact protein in the absence of ATP.
Equilibrium Dialysis-Equilibrium microdialyzers (Harvard Apparatus Inc.) containing two 25-l chambers separated by a 10,000-dalton molecular mass cutoff dialysis membrane were used. One chamber contained protein in buffer D, and the other chamber contained [␥-32 P]ATP (Amersham Biosciences, Inc.) in buffer D. A 48 h incubation at 4°C was required to achieve equilibrium. Three 5-l samples were drawn from each side of microdialyzers and counted with a Beckman LS 7800 liquid scintillation counter. Control experiments lacking protein were included to ensure that equilibrium was achieved. In all experiments, more than 90% of the protein remained soluble after the 48-h incubation.
RESULTS
A 43-kilodalton NH 2 -terminal domain (NTD) of E. coli DNA gyrase B, a GHKL family member, was previously used to study ATP binding and hydrolysis (16, 17) , and a similar NTD of E. coli MutL also binds and hydrolyzes ATP (6) . Based on these precedents, we began this study using NTDs of yeast Mlh1 and Pms1 proteins that were identified by proteolysis and mass spectrometry. 2 These proteins (Fig. 1A) contain the first 343 amino acids of Mlh1 and amino acids 32-396 of Pms1. The latter choice was prompted by structure-based sequence alignments (7) and by in vivo complementation studies with plasmid-borne yeast PMS1 genes containing a mutation in either codon 1 or 32 and studies mapping the 5Ј end of PMS1 mRNA (10) . 3 These approaches indicate that functional Pms1 can be expressed using methionine codon 32 of the published PMS1 sequence as a start codon for translation. To avoid confusion relative to the published amino acid numbering for yeast Pms1, the NTD of Pms1 is designated here as Pms1(396), while the corresponding Mlh1 NTD is designated Mlh1(343). Both proteins were overproduced in E. coli and purified to apparent homogeneity ( Fig. 2) .
ATP Hydrolysis-When the purified Mlh1(343) and Pms1(396) preparations were examined for the ability to hydrolyze ATP, ATPase activities were readily detected (compare first and last three lanes in Fig. 3 , A and B). To determine whether these ATPase activities were intrinsic to Mlh1(343) and Pms1(396), we purified two different mutant derivatives predicted to lack ATPase activity. In the crystal structure of the MutL NTD, a conserved Asn (residue 35 in Mlh1 and 65 in Pms1, Fig. 1 , B and C) participates in coordinating a Mg 2ϩ ion thought to be required for ATP binding (6) . Based on crystal structures of NTDs of gyrase B and MutL (6, 18) and biochemical studies of gyrase B (19), Glu-31 in Mlh1 and Glu-61 in Pms1 (Fig. 1 , B and C) may serve as general bases for catalyzing ATP hydrolysis. Mlh1(343) and Pms1(396) proteins with homologous N35A and N65A substitutions have levels of ATPase activity that are reduced by 84 and 95%, respectively (Fig. 3, A and B, and Table I ). The E31A and E61A mutant preparations also had decreased ATPase activities (Table I ). These data indicate that the majority of the ATPase activities in the wild-type protein preparations are intrinsic to Mlh1(343) and Pms1(396). The weak ATPase activities detected in the mutant protein preparations (Table I ) may reflect contaminating ATPase that is too faint to be seen by SDS-PAGE. For example, the N35A mutant of Mlh1(343), which does not interact significantly with ATP (see below), still exhibited an ATPase level 18% that of wild-type Mlh1(343). This residual activity is more apparent in Mlh1(343) mutant preparations, because the k cat for ATPase activity of Mlh1(343) is weaker than that of Pms1(396) ( Table I) .
Functional Defects in MMR Due to Mutations in ATPase Active Site Residues-To determine whether loss of ATPase activity in the mutant proteins correlates with loss of MMR in vivo, we examined mutation rates at three different loci in haploid yeast strains harboring these same mutations. The mlh1-N35A and pms1-N65A mutations both resulted in a strong mutator phenotype indistinguishable from that of the mlh1 deletion or pms1 deletion strain. The mlh1-E31A and pms1-E61A mutations were also mutators (Table II) , consistent with a previous report (9) . Immunoblot analysis indicated that the level of expression of wild-type, E31A, and N35A Mlh1p in the three haploid yeast strains was similar (data not shown).
Parallel attempts with the pms1 strains were unsuccessful, because there was insufficient Pms1 expressed from the natural promoter on the chromosome to detect using anti-Pms1.
Note that the pms1-E61A mutation only conferred a weak mutator phenotype (60-fold, as compared with 11,000-fold for the mlh1 deletion mutant), despite a 50-fold reduction in ATPase activity by the mutant protein (Table I ). In contrast, the decrease in ATPase activity of Mlh1-E31A resulted in a severe reduction of mismatch repair in vivo. The reduced ATPase activity of Pms1-E61A may be sufficient for completion of the majority of mismatch repair events, whereas completion of repair is apparently more sensitive to perturbation of the Mlh1 ATPase activity.
Semidominant Mutator Effect of N35A Mutation-To determine whether the mlh1 or pms1 mutations confer a mutator phenotype in the presence of the wild-type MLH1 or PMS1 alleles, we constructed diploid yeast strains heterozygous for each of the four missense mutations. The MLH1/mlh1⌬ strain heterozygous for mlh1 deletion has a Lys ϩ reversion rate elevated 3-5-fold (Table III) . We showed previously that this mutator effect results from loss of the wild-type MLH1 allele in a small fraction of cells rather than reduced MMR capacity in the heterozygous cells (12) . Heterozygosity for the mlh1-E31A or pms1-E61A mutations did not increase the mutation rate above the increase conferred by heterozygosity for mlh1 deletion (Table III) . However, heterozygosity for the mlh1-N35A mutation led to a 480-fold elevation of mutation rate. This suggests that the mutant Mlh1p inhibits MMR by wild-type Mlh1p, albeit not completely, since deletion of mlh1 results in an 11,000-fold mutator effect. In contrast to the results with the mlh1-N35A mutation, the analogous pms1-N65A mutation did not confer a dominant mutator effect. The semidominant effect of mlh1-N35A, but not pms1-N65A, and the differential mutator effects of mlh1-E31A and pms1-E61A mutations in haploid strains, are both consistent with the idea of functional asymmetry within the Mlh1-Pms1 heterodimer. This interpretation is qualified by the fact that the N65A Pms1 expression level from the natural promoter is unknown, although we do note the N65A substitution did not adversely affect solubility or the stability of Pms1(396) overproduced in E. coli (Fig. 2) . Kinetic Analysis of ATP Binding and Hydrolysis-Next, the ATPase activities of the wild-type Mlh1(343) and Pms1(396) proteins were measured as a function of increasing ATP concentration (Fig. 3, C and D Table I ), such that the catalytic efficiencies of the two proteins differ by only 3-fold (k cat /K m of 3 ϫ 10 Ϫ4 for Mlh1(343) and 1 ϫ 10 Ϫ4 for Pms1(396)). The large difference in K m between Mlh1(343) and Pms1(396) illustrates a biochemical asymmetry in the Mlh1-Pms1 heterodimer that may be related to the functional asymmetry observed in vivo.
ATPase Activity of Intact Mlh1-Pms1 Heterodimer-Because the NTD of E. coli MutL hydrolyzes ATP at a 10-fold lower rate than does full-length MutL (6), we tested whether intact yeast Mlh1-Pms1 heterodimer possesses higher ATPase activity than Mlh1(343) and Pms1(396). When purified as described previously (10) and analyzed under conditions similar to those used in Fig. 3A , the Mlh1-Pms1 preparation hydrolyzes ATP at a rate of 0.3-0.4 min Ϫ1 . This rate is only slightly higher than the combined rates for the individual NTDs. Difficulties in purifying the N35A/N65A double mutant heterodimer preclude the interpretation that all this ATPase activity is intrinsic to Mlh1-Pms1. Nonetheless, we conclude that the ATPase activity of the heterodimer is weak and not substantially greater than that of the individual NTDs.
Limited Proteolysis Asssays-Given the large difference in affinity for ATP suggested by ATPase assays, we examined ATP binding by Mlh1(343) and Pms1(396) in more detail. Ligand binding often induces conformational changes in proteins that can be monitored by limited proteolysis. For example, the addition of ATP to the Mlh1-Pms1 heterodimer was shown by immunoblotting to protect the amino terminus of Mlh1 from trypsin proteolysis (9) . We used the individual NTDs of Mlh1 and Pms1 here, rather than the Mlh1-Pms1 heterodimer, to examine the effect of ATP on proteolysis, because the resulting Table I. full-length Mlh1-Pms1 heterodimer yields essentially the same results due to rapid cleavage of a very sensitive proteolytic cleavage site, presumably in an exposed interdomain region separating the NTDs from COOH-terminal heterodimerization regions. 2 Both Mlh1(343) and Pms1(396) were protected from limited trypsin proteolysis when ATP was present (Fig. 4) . However, there was a large difference in the ATP concentration required to protect Mlh1(343) and Pms1(396) (Fig. 4, A and C versus B  and D) . The concentration of ATP required to achieve halfmaximal protection (K ATP in Table I ) was 14-fold lower for Mlh1(343) (130 M) than for Pms1(396) (1.9 mM). This suggests that Mlh1(343) binds ATP with higher affinity than Pms1(396). The K ATP values for Mlh1(343) and Pms1(396) are remarkably similar to the K m values obtained in ATPase assays, providing further evidence that the observed ATPase activities are intrinsic to Mlh1(343) and Pms1(396).
We then examined the mutant derivatives of Mlh1(343) and Pms1(396) in proteolysis protection assays. Consistent with the inferred role of the conserved asparagine residue in ATP binding, the N35A mutant of Mlh1(343) and the N65A mutant of Pms1(396) were protected from trypsin proteolysis by ATP to a lesser extent than the wild-type proteins (Fig. 4) . We also observed lower ATP-dependent protection of the E61A mutant (Fig. 4, B and D) , suggesting that its ATP binding capacity may also be somewhat lower. However, the degree of the ATP binding defects of E61A and N65A is difficult to quantitate, because the affinity of Pms1(396) for ATP is already very low. Thus, it is possible that these two mutants possess ATP binding defects of different severity that could not be distinguished in this assay. Our in vivo results on mutation rates (Table II) support this possibility. The E31A mutant was protected by ATP (Fig.  4, A and C) but yielded a K ATP value (660 M) that was 5-fold higher than for wild-type Mlh1(343). This suggests that the E31A mutant can still bind ATP but has a lower affinity, which is consistent with the lower ATP binding affinity reported for the homologous E29A mutant of E. coli MutL (6). The proteolysis patterns of all mutants (not shown) were not significantly different from their respective wild-type proteins. In multiple experiments, the extent of proteolysis in the absence of ATP was not significantly different among the mutant and wild-type proteins. However, the sensitivity of this approach does not rule out the possibility of slight conformational differences caused by the amino acid changes.
Equilibrium Dialysis-To obtain direct evidence for differential ATP binding by the two MutL homologs, we measured binding of ATP to Mlh1(343), Pms1(396), and the N35A mutant of Mlh1(343) by equilibrium dialysis (Fig. 5) . Consistent with the proteolysis results, Mlh1(343) clearly bound ATP at concentrations between 6 and 100 M (closed circles). In contrast, Pms1(396) did not bind ATP in this same concentration range. These data provide direct confirmation that the large differences between Mlh1(343) and Pms1(396) in K m and K ATP (Table I) are due to differences in their ATP binding affinities. As predicted for the role of Asn-35 in coordinating Mg 2ϩ , no ATP binding was detected with the Mlh1(343) N35A mutant protein. b Three separate trials were averaged together and fit with the Michaelis-Menten equation using Kaleidagraph to give the K m and standard error.
c Relative ATPase rates per pmol of protein were measured at 1 mM ATP for Mlh1(343) mutants and at 10 mM ATP for Pms1(396) mutants. The k cat values for wild-type proteins were set to 1 for the comparisons. The values for mutants do not represent true k cat values, because the ATP concentrations are not saturating. Protein concentrations were 9 M for E31A, 28 M for N35A, 21 M for E61A, and 12 M for N65A. Results represent the average of three independent experiments.
d Three separate experiments were combined to obtain an average data set that was fit with a rectangular hyperbola using Kaleidagraph to yield K ATP Ϯ S.E. values. N ϭ not measurable. a Reversion rates were measured for diploid strains heterozygous for mlh1 or pms1 mutations and an isogenic wild-type diploid strain.
b Rates are given as medians for nine independent cultures, with 95% confidence limits in parentheses.
c Relative to the wild-type mutation rate.
DISCUSSION
We have demonstrated that NTDs of yeast Mlh1 and Pms1 proteins bind and hydrolyze ATP, consistent with the presence of conserved GHKL family ATP binding motifs. The rates of ATP hydrolysis by both proteins and the intact Mlh1-Pms1 heterodimer are similar to those of other family members, including yeast Hsp90 and MutL, whose k cat values are ϳ0.4 min Ϫ1 (7, 20, 21) . Such weak ATPase activity is probably not used for a motor function but rather to drive conformational changes within the protein itself that affect its association with other DNA repair components (22) . This idea has been previously discussed by Tran and Liskay (9) and is supported by the present study. MutL homologs may use the energy of ATP hydrolysis only to return the enzyme to its initial conformation to participate in another round of repair. Such a mechanism was previously proposed for gyrase B (23) . In this scenario, it may be ATP binding that is key to promoting protein conformational changes that facilitate downstream events in MMR. For example, ATP binding is sufficient for E. coli MutL to activate the MutH endonuclease (7, 24) . The similar strong mutator effects of mlh1-N35A and pms1-N65A mutations suggest that ATP binding by both Mlh1 and Pms1 is essential for MMR, while weaker mutator effects of mlh1-E31A and pms1-E61A suggest that a significant fraction of repair events can be completed in the absence or reduction of Mlh1 or Pms1 ATPase activity.
Amino acids that are important for ATPase activity in the NTD of E. coli MutL are disordered in the crystal structure of the monomer (7) but become properly ordered upon homodimerization (6) . Current evidence suggests that dimerization of the NTDs of other GHKL proteins such as MutL and gyrase B is essential for ATPase activity (6, 16) . It is worth noting that all previously studied GHKL family ATPases normally function as homodimers. However, Mlh1 and Pms1 are thought to normally function as a heterodimer during mis- Neither of the mutations in Mlh1(343) or Pms1(396) drastically altered the pattern of proteolytic fragments (not shown). NP, control reactions without protease. C, the percent protection at each ATP concentration for wild-type Mlh1(343) (q) and the E31A (OE) and N35A (ࡗ) mutants was quantitated by digital image analysis of proteolysis gels (such as those in A) as described under "Experimental Procedures." The average results from at least three independent experiments were plotted as a function of ATP concentration. Solid lines are nonlinear least squares curve fits using the equation for a rectangular hyperbola. K ATP values obtained from these curve fits are reported in Table  I . D, the same analysis was performed for proteolysis experiments such as those represented in B with Pms1(396) (q) and the E61A (OE) and N65A (ࡗ) mutants. match repair. In this study, the Mlh1(343) and Pms1(396) proteins catalyze ATP hydrolysis in the absence of their partner in the normal heterodimer. Thus, it is formally possible that the NTDs of Mlh1(343) and Pms1(396) can homodimerize, as has been detected with intact Mlh1 in the absence of intact Pms1 (11) . However, we have been unable to detect homodimerization by glutaraldehyde crosslinking experiments 2 in the presence and absence of ATP or the nonhydrolyzable analog ADPNP, suggesting that these NTDs are primarily monomeric in solution. This suggests that, unlike the NTD of E. coli MutL and other homodimeric GHKL family members, the weak ATPase active sites in the NTDs of Mlh1 and Pms1 may function as monomers. In support of this, recent studies of an NTD of human PMS2 indicate that it too hydrolyzes ATP, yet dimerization is not detected by gel filtration, protein crosslinking, or equilibrium ultracentrifugation in the presence of nonhydrolyzable ATP analogues (25) .
Kinetic analysis of ATP hydrolysis (Table I) , ATP-dependent protection against proteolysis (Fig. 4) , and direct equilibrium binding data (Fig. 5) all suggest that Mlh1(343) has a higher ATP binding affinity than does Pms1(396). This is consistent with a model wherein ATP binds to Mlh1 first, then to Pms1. If so, then ATP-dependent conformational changes in Mlh1 and Pms1 may occur sequentially and modulate different events required to search for the strand discrimination signal, excise the mismatch, and resynthesize the nascent DNA strand. This is further suggested by the fact that mutations in conserved residues in the putative ATP binding pockets of Mlh1 and Pms1 have different effects on mutation rates in vivo. Thus, Tran and Liskay first demonstrated (9) and we now confirm (Table II) that the E31A mutation in yeast Mlh1 confers a much stronger mutator phenotype than does the homologous E61A mutation in Pms1. We further show here that the N35A mutation in Mlh1 produces a semidominant effect while the N65A mutation in Pms1 does not.
Although the exact nature and ordering of the many interactions that occur during mismatch repair remain to be determined, the semidominant effect of mlh1-N35A mutation but not the pms1-N65A mutation may be instructive. Apparently, the inability of Mlh1-N35A to bind ATP and change conformation not only disrupts MMR, but also partially inhibits MMR by wild-type proteins present in heterozygous diploid cells (Table  III) . Thus, it is possible that Mlh1-N35A might still interact with MutS homologs or other proteins (e.g. PCNA) but may not be able to recruit the downstream factors necessary for mismatch processing. This inactive complex may block access to the mismatch by wild-type proteins to prevent repair of a fraction of mismatches. However, the corresponding N65A mutation in Pms1, which also results in a complete MMR defect in a haploid strain, does not produce a mutator phenotype in a heterozygous diploid strain. It is possible that an ATP-induced conformational change in Pms1 may occur at a later stage when the mismatch is no longer occupied by a protein complex. In this case, abortive repair attempts by mutant proteins would not prevent repair by wild-type proteins. In this model, the semidominant effect of the mlh1-N35A mutation, but not the pms1-N65A mutation, is consistent with sequential binding of ATP, first to Mlh1, then to Pms1.
Other models are of course possible. The enormous complexity of the DNA mismatch repair pathway is illustrated by the fact that, like MutL proteins, MutS proteins also form asymmetric dimers that contain two ATPase active sites thought to sequentially bind and hydrolyze ATP (reviewed in Ref. 26 ). MutS and MutL dimers interact with a variety of different DNA substrates and with a number of other proteins to fulfill their roles in MMR, transcription-coupled repair, checkpoint control, apoptosis, and recombination. For some of these roles, it will also be interesting to determine whether other MutL homologs that partner with Mlh1, such as Mlh2 and Mlh3, have low ATP binding affinities like that of Pms1.
